日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Cancer-Associated Fibroblasts Genes and Transforming Growth Factor Beta Pathway in Gastric Cancer for Novel Therapeutic Strategy

胃癌中与癌症相关的成纤维细胞基因和转化生长因子β通路：一种新的治疗策略

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17050795
Minoura, Hiroyuki; Okamoto, Riku; Hiki, Naoki; Yamashita, Keishi
胃癌
信号转导
成纤维细胞
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Comparative Oncology: Cross-Sectional Single-Cell Transcriptomic Profiling of the Tumor Microenvironment Across Seven Human Cancers

比较肿瘤学：七种人类癌症肿瘤微环境的横断面单细胞转录组分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17213527
Okamoto, Riku; Okuno, Kota; Watanabe, Akiko; Naito, Kanako; Minoura, Hiroyuki; Shibaki, Shumpei; Ikemura, Kyonosuke; Oki, Keiko; Kuroda, Yu; Fujino, Shiori; Nie, Yusuke; Nishizawa, Nobuyuki; Watanabe, Eiichiro; Kikuchi, Mariko; Kumagai, Koshi; Yamanashi, Takahiro; Katoh, Hiroshi; Takayasu, Hajime; Sato, Takeo; Sangai, Takafumi; Kumamoto, Yusuke; Naitoh, Takeshi; Hiki, Naoki; Yamashita, Keishi
肿瘤
肿瘤免疫
Human
细胞生物学
肿瘤微环境
单细胞
发表日期：2025
文献求助 收藏

Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion

对于伴有显著喉气管侵犯的甲状腺癌，乐伐替尼可作为紧急初始治疗方案。

期刊:European Thyroid Journal
影响因子:4.3
doi:10.1530/ETJ-25-0212
Katoh, Hiroshi; Okamoto, Riku; Ozawa, Yuka; Tokito, Takaaki; Kikuchi, Mariko; Sangai, Takafumi
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion

作者回复 Martinod 等人来信，信中探讨了使用乐伐替尼作为甲状腺癌伴显著喉气管侵犯患者的紧急初始治疗方案的合理性。

期刊:European Thyroid Journal
影响因子:4.3
doi:10.1530/ETJ-25-0377
Katoh, Hiroshi; Okamoto, Riku; Ozawa, Yuka; Tokito, Takaaki; Kikuchi, Mariko; Sangai, Takafumi
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

A quantitative amplitude of vagus nerve obtained by intraoperative neuromonitoring predicts postoperative vocal cord paralysis among patients in thyroid/parathyroid surgery as a second option

术中神经监测获得的迷走神经定量振幅可预测甲状腺/甲状旁腺手术患者术后声带麻痹，作为第二选择。

期刊:Surgery Open Science
影响因子:1.7
doi:10.1016/j.sopen.2024.12.009
Katoh, Hiroshi; Okamoto, Riku; Naito, Kanako; Mitsuma, Tomoya; Kikuchi, Mariko; Tokito, Takaaki; Naitoh, Takeshi; Hiki, Naoki; Kumamoto, Yusuke; Sangai, Takafumi
免疫/内分泌
发表日期：2025
文献求助 收藏

Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection

病理转移性淋巴结密度（ND）可预测乳头状甲状腺癌患者根治性切除术后的早期复发。

期刊:Gland Surgery
影响因子:1.6
doi:10.21037/gs-2025-36
Okamoto, Riku; Katoh, Hiroshi; Naito, Kanako; Mitsuma, Tomoya; Ozawa, Yuka; Tokito, Takaaki; Kikuchi, Mariko; Yamashita, Keishi; Sangai, Takafumi
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer

CAF相关基因可能通过结肠癌基质成分的计算机模拟分析，代表不同的预后

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0299827
Okuno, Kota; Ikemura, Kyonosuke; Okamoto, Riku; Oki, Keiko; Watanabe, Akiko; Kuroda, Yu; Kidachi, Mikiko; Fujino, Shiori; Nie, Yusuke; Higuchi, Tadashi; Chuman, Motohiro; Washio, Marie; Sakuraya, Mikiko; Niihara, Masahiro; Kumagai, Koshi; Sangai, Takafumi; Kumamoto, Yusuke; Naitoh, Takeshi; Hiki, Naoki; Yamashita, Keishi
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature

帕博利珠单抗联合体外放射治疗有效控制了TMB高表达的不可切除复发性甲状旁腺癌：病例报告及文献复习

期刊:Endocrine Journal
影响因子:2.1
doi:10.1507/endocrj.EJ24-0126
Katoh, Hiroshi; Mitsuma, Tomoya; Okamoto, Riku; Naito, Kanako; Tokito, Takaaki; Kikuchi, Mariko; Sangai, Takafumi
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Development of Organelle Replacement Therapy Using a Stearyl-Polyhistidine Peptide against Lysosomal Storage Disease Cells.

利用硬脂酰聚组氨酸肽开发针对溶酶体贮积症细胞的细胞器替代疗法

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules24162995
Hayashi Taiki, Okamoto Riku, Kawano Tsuyoshi, Iwasaki Takashi
细胞生物学
发表日期：2019
文献求助 收藏